Literature DB >> 33556142

Estimation of the fraction of COVID-19 infected people in U.S. states and countries worldwide.

Jungsik Noh1, Gaudenz Danuser1.   

Abstract

Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, daily counts of confirmed cases and deaths have been publicly reported in real-time to control the virus spread. However, substantial undocumented infections have obscured the true size of the currently infected population, which is arguably the most critical number for public health policy decisions. We developed a machine learning framework to estimate time courses of actual new COVID-19 cases and current infections in all 50 U.S. states and the 50 most infected countries from reported test results and deaths. Using published epidemiological parameters, our algorithm optimized slowly varying daily ascertainment rates and a time course of currently infected cases each day. Severe under-ascertainment of COVID-19 cases was found to be universal across U.S. states and countries worldwide. In 25 out of the 50 countries, actual cumulative cases were estimated to be 5-20 times greater than the confirmed cases. Our estimates of cumulative incidence were in line with the existing seroprevalence rates in 46 U.S. states. Our framework projected for countries like Belgium, Brazil, and the U.S. that ~10% of the population has been infected once. In the U.S. states like Louisiana, Georgia, and Florida, more than 4% of the population was estimated to be currently infected, as of September 3, 2020, while in New York this fraction is 0.12%. The estimation of the actual fraction of currently infected people is crucial for any definition of public health policies, which up to this point may have been misguided by the reliance on confirmed cases.

Entities:  

Mesh:

Year:  2021        PMID: 33556142      PMCID: PMC7869996          DOI: 10.1371/journal.pone.0246772

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  10 in total

1.  How deadly is the coronavirus? Scientists are close to an answer.

Authors:  Smriti Mallapaty
Journal:  Nature       Date:  2020-06       Impact factor: 49.962

2.  Preliminary Estimate of Excess Mortality During the COVID-19 Outbreak - New York City, March 11-May 2, 2020.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-05-15       Impact factor: 17.586

3.  Estimation of Excess Deaths Associated With the COVID-19 Pandemic in the United States, March to May 2020.

Authors:  Daniel M Weinberger; Jenny Chen; Ted Cohen; Forrest W Crawford; Farzad Mostashari; Don Olson; Virginia E Pitzer; Nicholas G Reich; Marcus Russi; Lone Simonsen; Anne Watkins; Cecile Viboud
Journal:  JAMA Intern Med       Date:  2020-10-01       Impact factor: 21.873

4.  Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020.

Authors:  Fiona P Havers; Carrie Reed; Travis Lim; Joel M Montgomery; John D Klena; Aron J Hall; Alicia M Fry; Deborah L Cannon; Cheng-Feng Chiang; Aridth Gibbons; Inna Krapiunaya; Maria Morales-Betoulle; Katherine Roguski; Mohammad Ata Ur Rasheed; Brandi Freeman; Sandra Lester; Lisa Mills; Darin S Carroll; S Michele Owen; Jeffrey A Johnson; Vera Semenova; Carina Blackmore; Debra Blog; Shua J Chai; Angela Dunn; Julie Hand; Seema Jain; Scott Lindquist; Ruth Lynfield; Scott Pritchard; Theresa Sokol; Lynn Sosa; George Turabelidze; Sharon M Watkins; John Wiesman; Randall W Williams; Stephanie Yendell; Jarad Schiffer; Natalie J Thornburg
Journal:  JAMA Intern Med       Date:  2020-07-21       Impact factor: 21.873

5.  Estimates of the severity of coronavirus disease 2019: a model-based analysis.

Authors:  Robert Verity; Lucy C Okell; Ilaria Dorigatti; Peter Winskill; Charles Whittaker; Natsuko Imai; Gina Cuomo-Dannenburg; Hayley Thompson; Patrick G T Walker; Han Fu; Amy Dighe; Jamie T Griffin; Marc Baguelin; Sangeeta Bhatia; Adhiratha Boonyasiri; Anne Cori; Zulma Cucunubá; Rich FitzJohn; Katy Gaythorpe; Will Green; Arran Hamlet; Wes Hinsley; Daniel Laydon; Gemma Nedjati-Gilani; Steven Riley; Sabine van Elsland; Erik Volz; Haowei Wang; Yuanrong Wang; Xiaoyue Xi; Christl A Donnelly; Azra C Ghani; Neil M Ferguson
Journal:  Lancet Infect Dis       Date:  2020-03-30       Impact factor: 25.071

6.  Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York.

Authors:  Eli S Rosenberg; James M Tesoriero; Elizabeth M Rosenthal; Rakkoo Chung; Meredith A Barranco; Linda M Styer; Monica M Parker; Shu-Yin John Leung; Johanne E Morne; Danielle Greene; David R Holtgrave; Dina Hoefer; Jessica Kumar; Tomoko Udo; Brad Hutton; Howard A Zucker
Journal:  Ann Epidemiol       Date:  2020-06-17       Impact factor: 3.797

7.  Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.

Authors:  Kelvin Kai-Wang To; Owen Tak-Yin Tsang; Wai-Shing Leung; Anthony Raymond Tam; Tak-Chiu Wu; David Christopher Lung; Cyril Chik-Yan Yip; Jian-Piao Cai; Jacky Man-Chun Chan; Thomas Shiu-Hong Chik; Daphne Pui-Ling Lau; Chris Yau-Chung Choi; Lin-Lei Chen; Wan-Mui Chan; Kwok-Hung Chan; Jonathan Daniel Ip; Anthony Chin-Ki Ng; Rosana Wing-Shan Poon; Cui-Ting Luo; Vincent Chi-Chung Cheng; Jasper Fuk-Woo Chan; Ivan Fan-Ngai Hung; Zhiwei Chen; Honglin Chen; Kwok-Yung Yuen
Journal:  Lancet Infect Dis       Date:  2020-03-23       Impact factor: 25.071

8.  Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2).

Authors:  Ruiyun Li; Sen Pei; Bin Chen; Yimeng Song; Tao Zhang; Wan Yang; Jeffrey Shaman
Journal:  Science       Date:  2020-03-16       Impact factor: 47.728

9.  An interactive web-based dashboard to track COVID-19 in real time.

Authors:  Ensheng Dong; Hongru Du; Lauren Gardner
Journal:  Lancet Infect Dis       Date:  2020-02-19       Impact factor: 25.071

10.  Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study.

Authors:  Shuchi Anand; Maria Montez-Rath; Jialin Han; Julie Bozeman; Russell Kerschmann; Paul Beyer; Julie Parsonnet; Glenn M Chertow
Journal:  Lancet       Date:  2020-09-25       Impact factor: 202.731

  10 in total
  16 in total

1.  Genomic epidemiology of the first two waves of SARS-CoV-2 in Canada.

Authors:  Angela McLaughlin; Vincent Montoya; Rachel L Miller; Gideon J Mordecai; Michael Worobey; Art F Y Poon; Jeffrey B Joy
Journal:  Elife       Date:  2022-08-02       Impact factor: 8.713

2.  COVID-19 Classification from Chest X-Ray Images: A Framework of Deep Explainable Artificial Intelligence.

Authors:  Muhammad Attique Khan; Marium Azhar; Kainat Ibrar; Abdullah Alqahtani; Shtwai Alsubai; Adel Binbusayyis; Ye Jin Kim; Byoungchol Chang
Journal:  Comput Intell Neurosci       Date:  2022-07-14

3.  Underdetection in a stochastic SIR model for the analysis of the COVID-19 Italian epidemic.

Authors:  Antonella Bodini; Sara Pasquali; Antonio Pievatolo; Fabrizio Ruggeri
Journal:  Stoch Environ Res Risk Assess       Date:  2021-08-28       Impact factor: 3.379

4.  Clinical and Economic Effects of Widespread Rapid Testing to Decrease SARS-CoV-2 Transmission.

Authors:  A David Paltiel; Amy Zheng; Paul E Sax
Journal:  Ann Intern Med       Date:  2021-03-09       Impact factor: 51.598

5.  We Can Dance If We Want To (with Safety Measures).

Authors:  Susan Carson
Journal:  mBio       Date:  2022-02-28       Impact factor: 7.786

6.  Neutralization of SARS-CoV-2 variants by convalescent and vaccinated serum.

Authors:  Timothy A Bates; Hans C Leier; Zoe L Lyski; Savannah K McBride; Felicity J Coulter; Jules B Weinstein; James R Goodman; Zhengchun Lu; Sarah A R Siegel; Peter Sullivan; Matt Strnad; Amanda E Brunton; David X Lee; Marcel E Curlin; William B Messer; Fikadu G Tafesse
Journal:  medRxiv       Date:  2021-04-09

7.  Immunization using a heterogeneous geo-spatial population model: A qualitative perspective on COVID-19 vaccination strategies.

Authors:  Alexandru Topîrceanu
Journal:  Procedia Comput Sci       Date:  2021-10-01

8.  Estimates of global SARS-CoV-2 infection exposure, infection morbidity, and infection mortality rates in 2020.

Authors:  Houssein H Ayoub; Ghina R Mumtaz; Shaheen Seedat; Monia Makhoul; Hiam Chemaitelly; Laith J Abu-Raddad
Journal:  Glob Epidemiol       Date:  2021-11-23

9.  Analysis of accumulated SARS-CoV-2 seroconversion in North Carolina: The COVID-19 Community Research Partnership.

Authors:  John C Williamson; Thomas F Wierzba; Michele Santacatterina; Iqra Munawar; Austin L Seals; Christine Ann Pittman Ballard; Martha Alexander-Miller; Michael S Runyon; Lewis H McCurdy; Michael A Gibbs; Amina Ahmed; William H Lagarde; Patrick D Maguire; Robin King-Thiele; Terri Hamrick; Abdalla Ihmeidan; Shakira Henderson; T Ryan Gallaher; Diane Uschner; Sharon L Edelstein; David M Herrington; John W Sanders
Journal:  PLoS One       Date:  2022-03-18       Impact factor: 3.240

10.  Towards an Accurate Estimation of COVID-19 Cases in Kazakhstan: Back-Casting and Capture-Recapture Approaches.

Authors:  Antonio Sarría-Santamera; Nurlan Abdukadyrov; Natalya Glushkova; David Russell Peck; Paolo Colet; Alua Yeskendir; Angel Asúnsolo; Miguel A Ortega
Journal:  Medicina (Kaunas)       Date:  2022-02-08       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.